Nobel Prize-winning discoveries about an enzyme capable of killing malignant cancer cells started Geron's journey.
As Geron advances towards FDA approval, their website needed to become a flexible, editorial driven experience, capable of supporting ongoing industry content, as well as new levels of investor, and media attention.
A modular, grid-based architecture allows for nearly any combination of content, and graphics to be easily showcased, and updated from a single CMS.
Geron's brand was also enhanced with a series of custom gradients, and infographics to emphasize their bold outlook, determination to improve lives around the world, and spotlight the milestones on their journey to commercialization.
